Crossref
Most RAS‐mutant early‐onset colorectal cancer have no matched therapy: extended RAS subtyping in the South Australian Young‐Onset Colorectal Cancer (SAYO) cohort
Asia-Pacific Journal of Clinical Oncology · 2026-11 · 22 (S6) · 73-73
DOI: 10.1111/ajco.70288 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asia-Pacific Journal of Clinical Oncology, online erschienen am 19.11.2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Most RAS‐mutant early‐onset colorectal cancer have no matched therapy: extended RAS subtyping in the South Australian Young‐Onset Colorectal Cancer (SAYO) cohort. Asia-Pacific Journal of Clinical Oncology, 22(S6), 73-73. https://doi.org/10.1111/ajco.70288
Vancouver
Most RAS‐mutant early‐onset colorectal cancer have no matched therapy: extended RAS subtyping in the South Australian Young‐Onset Colorectal Cancer (SAYO) cohort. Asia-Pacific Journal of Clinical Oncology. 2026;22(S6):73-73. doi:10.1111/ajco.70288
BibTeX
@article{euvimed2026,
title = {Most RAS‐mutant early‐onset colorectal cancer have no matched therapy: extended RAS subtyping in the South Australian Young‐Onset Colorectal Cancer (SAYO) cohort},
journal = {Asia-Pacific Journal of Clinical Oncology},
year = {2026},
volume = {22},
number = {S6},
pages = {73--73},
doi = {10.1111/ajco.70288}
}
EUVIMED